Macrogenics (MGNX) Non-Current Deffered Revenue (2012 - 2025)

Macrogenics (MGNX) has 14 years of Non-Current Deffered Revenue data on file, last reported at $55.5 million in Q4 2025.

• Non-Current Deffered Revenue for Q4 2025 came in at $55.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $55.5 million (changed 0.0% YoY), and the FY2025 annual result was $55.5 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue slipped to $55.5 million in Q4 2025 per MGNX's latest filing, from $55.8 million in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $64.3 million in Q3 2023 and troughed at $7.3 million in Q1 2021.
• A 5-year average of $49.8 million and a median of $55.9 million in 2025 frame the typical range for Non-Current Deffered Revenue.
• The sharpest annual moves came in 2022 and 2024: Non-Current Deffered Revenue surged 690.63% in 2022, then declined 13.63% in 2024.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $9.6 million in 2021, then soared by 521.2% to $59.5 million in 2022, then slipped by 0.4% to $59.2 million in 2023, then fell by 6.31% to $55.5 million in 2024, then changed by 0.0% to $55.5 million in 2025.
• Business Quant data shows MGNX's Non-Current Deffered Revenue at $55.5 million in Q4 2025, $55.8 million in Q3 2025, and $55.7 million in Q2 2025.